The German Pain Society estimates the number of chronic pain patients in Germany alone at around 23 million people. These include, for example, cancer patients who suffer from severe, chronic pain that can usually only be treated with opioid analgesics. For these patients, among others, the SHS portfolio company Develco Pharma develops and produces orally […]

Unquote reports on the sale of homecare specialist Medigroba to the Löwenstein Group. The deal is SHS’s second exit of 2021; the GP sold its stake in Crystal LaserSystems to Silver Investment Partners in March 2021. SHS expects to launch fundraising for its next fund later in 2021.

In the course of a successful succession arrangement, Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH sells its shares in medigroba GmbH to Löwenstein Group With SHS as majority shareholder, medigroba has more than doubled revenue and tripled EBITDA in the last four and a half years Due to the continuing trend towards outpatient care, the medium-sized […]

ESG, SRI, impact investing: when did this start, and what is its importance in the healthcare sector?

AMW GmbH announced today that Dr. Konstantin Petropoulos has been appointed Chief Executive Officer (CEO) effective March 15, 2021 This expands Dr. Friedrich Tegel and Philipp Karbach to the existing management team.

The industry magazine “Plattform Life Sciences” asked investors and financing advisors about the mood after the Corona year 2020 and, among others, asked SHS partner Manfred Ulmer-Weber about current financing trends and how life science investors like SHS see the world “after” COVID-19.

In a Podcast Caroline Sai of EIT Health and our Partner Andre Zimmermann are discussing in which ways the new MDR is heavily affecting the whole European Medtech area – from start-ups to established medium-sized companies. In addition, SHS is out-lining in which way medium-sized companies and investors can team-up not only to overcome the economical challenges of the MDR for Medtechs but to prosper.

Tübingen-based healthcare investor SHS has provided capital and expertise to Crystal Laser Systems GmbH (CryLaS) on its way to becoming a leading, profitable provider of laser technology and is handing over the baton to Silver Investment Partners SIP CryLaS enjoys an excellent reputation worldwide in the healthcare, biotech and semiconductor sectors with pulsed and CW […]

Digitization is one of the major challenges facing the medtech industry. Those who want to master them need courage, know-how and capital.

‘Brexit is done’, as British Prime Minister Johnson wholeheartedly announced. But what does this mean for the SME-based healthcare and medtech sector? Read about it the current column by Dr. André Zimmermann.

The Single Use Support GmbH (SUS) product system for use in the deep-frozen transport of sensitive substances is well on its way to becoming the gold standard in liquid logistics. Companies all over the world, in the fields of life science, biotech and pharma, including firms engaged in research for coronavirus vaccines, rely on products […]

The Dutch medtech company Salvia BioElectronics B.V. specialises in the treatment of chronic migraine with electromedical solutions for neurostimulation. The news that Salvia has received the coveted Breakthrough Device Designation from the United States FDA gives creates a reason for hope among millions of migraine patients in the USA. This will significantly accelerate the approval […]